Process development and scale-up of recombinant protein vaccines
M11
Course Goals
Process development and scale-up of recombinant protein vaccines.
Timeline
Application Deadline:
1 June 2021
Course Dates:
11-12 October 2021 (2 days)
Organiser
Fraunhofer IME,
Aachen Germany
Participant Nr.: max. 15
Contact
Johannes Buyel
johannes.buyel@ime.fraunhofer.de
For questions on the application process: transvacinfo@euvaccine.eu
Course content
A list of the course contents is given on the General strategies in process development for recombinant protein production and purification in different host systems with a special focus on state of the art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification. Typical processes will be discussed using real-life equipment and examples.
Learning Outcomes
Comprehensive insight into the possibilities to conduct and improve process development and scale-up of biomanufacturing processes.
Who should apply
Scientists involved or interested in vaccine R&D and manufacturing projects.
Minimal requirements
Basic understanding of recombinant DNA technology, protein chemistry and typical process unit operations.
Accommodation
Accommodation will be provided. Travel Costs are not included.
Comments
* Due to COVID19 related delays call and training modules' schedule may be subject to change.
Weblink
NA